128 related articles for article (PubMed ID: 24307622)
1. CCNG2 expression is downregulated in colorectal carcinoma and its clinical significance.
Sun GG; Zhang J; Hu WN
Tumour Biol; 2014 Apr; 35(4):3339-46. PubMed ID: 24307622
[TBL] [Abstract][Full Text] [Related]
2. Changes in the expression of cyclin G2 in esophageal cancer cell and its significance.
Chen JQ; Liu CJ; Wen HX; Shi CL; Zhang HS; Li M; Sun GG
Tumour Biol; 2014 Apr; 35(4):3355-62. PubMed ID: 24297335
[TBL] [Abstract][Full Text] [Related]
3. Change in expression of cyclin G2 in kidney cancer cell and its significance.
Cui DW; Sun GG; Cheng YJ
Tumour Biol; 2014 Apr; 35(4):3177-83. PubMed ID: 24272084
[TBL] [Abstract][Full Text] [Related]
4. Decreased expression of CCNG2 is significantly linked to the malignant transformation of gastric carcinoma.
Sun GG; Hu WN; Cui DW; Zhang J
Tumour Biol; 2014 Mar; 35(3):2631-9. PubMed ID: 24248541
[TBL] [Abstract][Full Text] [Related]
5. Effect of cyclin G2 on proliferative ability of prostate cancer PC-3 cell.
Cui DW; Cheng YJ; Jing SW; Sun GG
Tumour Biol; 2014 Apr; 35(4):3017-24. PubMed ID: 24293374
[TBL] [Abstract][Full Text] [Related]
6. CCNG2 suppressor biological effects on thyroid cancer cell through promotion of CDK2 degradation.
Li WJ; Liu GL; Yu F; Xiang XX; Lu YF; Xiao HZ; Shi YP
Asian Pac J Cancer Prev; 2013; 14(10):6165-71. PubMed ID: 24289643
[TBL] [Abstract][Full Text] [Related]
7. Farnesoid X receptor inhibits proliferation of human colorectal cancer cells via the miR‑135A1/CCNG2 signaling pathway.
Qiao P; Li S; Zhang H; Yao L; Wang F
Oncol Rep; 2018 Oct; 40(4):2067-2078. PubMed ID: 30106441
[TBL] [Abstract][Full Text] [Related]
8. MicroRNA-93 regulates cyclin G2 expression and plays an oncogenic role in laryngeal squamous cell carcinoma.
Xiao X; Zhou L; Cao P; Gong H; Zhang Y
Int J Oncol; 2015 Jan; 46(1):161-74. PubMed ID: 25309979
[TBL] [Abstract][Full Text] [Related]
9. MiR-1290 targets CCNG2 to promote the metastasis of oral squamous cell carcinoma.
Qin WJ; Wang WP; Wang XB; Zhang XT; Du JD
Eur Rev Med Pharmacol Sci; 2019 Dec; 23(23):10332-10342. PubMed ID: 31841213
[TBL] [Abstract][Full Text] [Related]
10. MicroRNA-1246 promotes growth and metastasis of colorectal cancer cells involving CCNG2 reduction.
Wang S; Zeng Y; Zhou JM; Nie SL; Peng Q; Gong J; Huo JR
Mol Med Rep; 2016 Jan; 13(1):273-80. PubMed ID: 26573378
[TBL] [Abstract][Full Text] [Related]
11. The expression of BTG1 is downregulated in NSCLC and possibly associated with tumor metastasis.
Sun GG; Lu YF; Cheng YJ; Hu WN
Tumour Biol; 2014 Apr; 35(4):2949-57. PubMed ID: 24264312
[TBL] [Abstract][Full Text] [Related]
12. CCNG2 and CDK4 is associated with insulin resistance in adipose tissue.
Garrido-Sánchez L; Roca-Rodríguez Mdel M; Fernández-Veledo S; Vendrell J; Yubero-Serrano EM; Ocaña-Wilhelmi L; García-Fuentes E; Tinahones FJ
Surg Obes Relat Dis; 2014; 10(4):691-6. PubMed ID: 24708911
[TBL] [Abstract][Full Text] [Related]
13. Cyclin G2 upregulation impairs migration, invasion, and network formation through RNF123/Dvl2/JNK signaling in the trophoblast cell line HTR8/SVneo, a possible role in preeclampsia.
Sun M; Gao J; Meng T; Liu S; Chen H; Liu Q; Xing X; Zhao C; Luo Y
FASEB J; 2021 Feb; 35(2):e21169. PubMed ID: 33205477
[TBL] [Abstract][Full Text] [Related]
14. An antiproliferative gene FLNA regulates migration and invasion of gastric carcinoma cell in vitro and its clinical significance.
Sun GG; Sheng SH; Jing SW; Hu WN
Tumour Biol; 2014 Mar; 35(3):2641-8. PubMed ID: 24241900
[TBL] [Abstract][Full Text] [Related]
15. MicroRNA-378a-5p targets cyclin G2 to inhibit fusion and differentiation in BeWo cells.
Nadeem U; Ye G; Salem M; Peng C
Biol Reprod; 2014 Sep; 91(3):76. PubMed ID: 25122062
[TBL] [Abstract][Full Text] [Related]
16. Epithelial membrane protein 1 negatively regulates cell growth and metastasis in colorectal carcinoma.
Sun GG; Wang YD; Cui DW; Cheng YJ; Hu WN
World J Gastroenterol; 2014 Apr; 20(14):4001-10. PubMed ID: 24744589
[TBL] [Abstract][Full Text] [Related]
17. Nodal enhances the activity of FoxO3a and its synergistic interaction with Smads to regulate cyclin G2 transcription in ovarian cancer cells.
Fu G; Peng C
Oncogene; 2011 Sep; 30(37):3953-66. PubMed ID: 21532621
[TBL] [Abstract][Full Text] [Related]
18. BTG1 expression correlates with the pathogenesis and progression of breast carcinomas.
Sheng SH; Zhao CM; Sun GG
Tumour Biol; 2014 Apr; 35(4):3317-26. PubMed ID: 24272202
[TBL] [Abstract][Full Text] [Related]
19. EMP1 inhibits nasopharyngeal cancer cell growth and metastasis through induction apoptosis and angiogenesis.
Sun GG; Lu YF; Fu ZZ; Cheng YJ; Hu WN
Tumour Biol; 2014 Apr; 35(4):3185-93. PubMed ID: 24292952
[TBL] [Abstract][Full Text] [Related]
20. Interactions between filamin A and MMP-9 regulate proliferation and invasion in renal cell carcinoma.
Sun GG; Wei CD; Jing SW; Hu WN
Asian Pac J Cancer Prev; 2014; 15(8):3789-95. PubMed ID: 24870795
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
